interleukin-1beta (163-171) has been researched along with phenyl-n-tert-butylnitrone in 1 studies
| Studies (interleukin-1beta (163-171)) | Trials (interleukin-1beta (163-171)) | Recent Studies (post-2010) (interleukin-1beta (163-171)) | Studies (phenyl-n-tert-butylnitrone) | Trials (phenyl-n-tert-butylnitrone) | Recent Studies (post-2010) (phenyl-n-tert-butylnitrone) |
|---|---|---|---|---|---|
| 192 | 3 | 74 | 624 | 3 | 66 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kalyanaraman, B; Ku, G; Thomas, CE | 1 |
1 other study(ies) available for interleukin-1beta (163-171) and phenyl-n-tert-butylnitrone
| Article | Year |
|---|---|
Nitrone spin trap lipophilicity as a determinant for inhibition of low density lipoprotein oxidation and activation of interleukin-1 beta release from human monocytes.
Topics: Cyclic N-Oxides; Electron Spin Resonance Spectroscopy; Humans; In Vitro Techniques; Interleukin-1; Interleukin-1beta; Lipoproteins, LDL; Monocytes; Nitrogen Oxides; Oxidation-Reduction; Peptide Fragments; Pyridines; Spin Labels | 1994 |